Chronic Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +2 more
  • Augusta, Georgia
  • +28 more
2021-10-11
Oct 11, 2021
N
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +86 more
2021-10-07
Oct 7, 2021
C
Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +2 more
2021-10-01
Oct 1, 2021
N
Recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +17 more
2021-09-28
Sep 28, 2021
N
Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Asciminib single agent
  • +6 more
  • (no location specified)
2021-09-14
Sep 14, 2021
M
Active, not recruiting
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-09-01
Sep 1, 2021
N
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2021-08-30
Aug 30, 2021
N
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
2021-08-18
Aug 18, 2021
E
Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
2021-08-18
Aug 18, 2021
H
Recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
2021-08-16
Aug 16, 2021
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Fludarabine (FLU)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-08-13
Aug 13, 2021
C
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • +9 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
2021-08-04
Aug 4, 2021
B
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
2021-08-06
Aug 6, 2021
C
Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    2021-07-26
    Jul 26, 2021
    B
    Not yet recruiting
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    2021-07-21
    Jul 21, 2021
    N
    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • ABL001 40mg BID
    • +2 more
    • (no location specified)
    2021-06-28
    Jun 28, 2021
    N
    Completed
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    2021-06-08
    Jun 8, 2021
    N
    Completed
    • Chronic Myelogenous Leukemia
    • +4 more
    • Miltenyi reagent system
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-05-25
    May 25, 2021
    H
    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Therapy for Targeted Therapy-related Fatigue (TTF)
    • Wait-List Control Condition (WLC)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-06-09
    Jun 9, 2021
    M
    Recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-05-21
    May 21, 2021
    M
    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-05-21
    May 21, 2021
    N
    Completed
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-05-20
    May 20, 2021